LifeStance Health Group, Inc. reported a third‑quarter 2025 revenue of $363.8 million, up 16% year‑over‑year and beating the consensus estimate of $355.6 million by $8.2 million, a 2.3% beat. The lift was driven by a 17% organic visit growth and the addition of 8,000 clinicians, which expanded the company’s reach across 33 states and 550 centers. The company’s strong demand for mental‑health services, coupled with a hybrid care model that blends virtual and in‑person visits, underpinned the revenue surge.
The company posted a net income of $1.1 million, a turnaround from a $6.0 million loss in Q3 2024 and a $3.8 million loss in Q2 2025. EPS of $0.00 surpassed the consensus of $-0.01, a $0.01 beat that reflects disciplined cost management and improved operating leverage. Adjusted EBITDA reached $40.2 million, an 11.1% margin—up from 9.8% a year earlier—thanks to higher mix of high‑margin services and scale‑related cost efficiencies.
Management reiterated its full‑year revenue outlook at $1.41 billion to $1.43 billion, a modest increase from the prior guidance of $1.40 billion to $1.42 billion, and raised its adjusted EBITDA guidance to $146 million to $152 million from $140 million to $146 million. The upward revision signals confidence that demand will continue to accelerate and that cost controls will sustain margin expansion into 2026.
Cash and cash equivalents stood at $203.9 million, while net long‑term debt remained at $269.4 million. The liquidity position is strong, with cash covering roughly 0.8× the debt, giving the company flexibility to invest in technology and further scale its clinician network.
CEO Dave Bourdon described the quarter as “record‑breaking,” noting that the 17% visit growth and 8,000‑clinician expansion were driven by “strongest‑ever organic productivity improvements.” He also highlighted opportunities to deploy technology and AI tools to reduce manual processes, while acknowledging that the company’s debt level remains a focus for future capital allocation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.